RhumbLine Advisers’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-760	Closed	-$16K	–	3269
2022 Q1	$16K	Sell	760 -79	-9%	-$1.66K	﹤0.01%	3004
2021 Q4	$50K	Hold	839	–	–	﹤0.01%	2981
2021 Q3	$79K	Sell	839 -26	-3%	-$2.45K	﹤0.01%	3007
2021 Q2	$143K	Buy	+865	New	+$143K	﹤0.01%	2948